MedPath

Magnesium sulphate in Tetanus

Completed
Conditions
Tetanus
Infections and Infestations
Registration Number
ISRCTN74651862
Lead Sponsor
niversity of Oxford (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
180
Inclusion Criteria

1. Adults with Ablett classification of tetanus severity grade three or four
2. Patient over 15 years with diagnosed tetanus
3. Tracheostomy more than six hours and not yet ventilated

Exclusion Criteria

1. Urine output less than 1 ml/kg/hr
2. Electrocardiogram (ECG) evidence of conduction abnormalities/ischaemia
3. Serum creatinine more than 1.5 mg%

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Requirement for mechanical ventilation primary outcome
Secondary Outcome Measures
NameTimeMethod
1. Requirement for benzodiazepines, pipecuronium, morphine and verapamil (mg/kg)<br>2. Hourly Systolic Blood Pressure (SBP) and Heart Rate (HR) recording and mean seven day maximum SBP, HR and daily variation in SBP<br>3. In hospital mortality (including patients taken home to die)<br>4. Length of Intensive Care Unit (ICU) stay, total hospital stay and total cost of hospital stay<br>5. Requirement for ventilation during hospital stay<br>6. Daily 8 am serum Creatinine Kinase (CK) measurement<br>7. Urinary epinephrine and norepinephrine, measured from a 24 hour collection on day two of the study
© Copyright 2025. All Rights Reserved by MedPath